Company Filing History:
Years Active: 2015
Title: Albertus A Ellenbroek: Innovator in Hepcidin Antagonists
Introduction
Albertus A Ellenbroek is a notable inventor based in Wellington, New Zealand. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of iron metabolism disorders. His innovative work has led to the development of novel compounds that have the potential to improve patient outcomes.
Latest Patents
Ellenbroek holds 1 patent for his invention titled "Sulfonaminoquinoline Hepcidin Antagonists." This patent relates to new hepcidin antagonists, pharmaceutical compositions that include these compounds, and their application as medicaments for treating iron deficiency diseases and anemias, especially those associated with chronic inflammatory conditions.
Career Highlights
Throughout his career, Ellenbroek has been dedicated to advancing medical science through his research and inventions. His work has been instrumental in addressing critical health issues related to iron metabolism, showcasing his commitment to improving healthcare solutions.
Collaborations
Ellenbroek has collaborated with esteemed colleagues, including Wilm Buhr and Susanna Burckhardt. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.
Conclusion
Albertus A Ellenbroek's contributions to the field of pharmaceuticals, particularly through his patent on hepcidin antagonists, highlight his role as a key innovator in addressing iron metabolism disorders. His work continues to pave the way for advancements in medical treatments.